Holland Capital invests in Data platform for medical research
Amsterdam/Düsseldorf, 19 December 2023 – Holland Capital invests in German company Honic for further development of their medical data platform.
Using this funding, Honic is able to further roll out its medical data platform. The platform – developed in cooperation with the German privacy regulator and various patient groups – is live since early 2022. The first research projects with universities and international life science companies have already been successfully conducted and completed. In cooperation with renowned partners such as Bundesdruckerei as data handler, IT security company Secunet, and Schwarz Group’s cloud provider StackIT, Honic offers a completely independent solution with its data platform.
Holland Capital led this funding round. Existing investors such as Dieter von Holtzbrinck Ventures, adesso Ventures and Isartal Ventures also participated in this round.
“In recent months, we have shown that the Honic platform is capable of making routinely collected medical data from routine care available for further research. With Holland Capital’s investment, we will further expand the Honic data infrastructure and unlock new data sources to play a pivotal role in the emerging European Health Data Space (EHDS),” said dr. Henrik Matthies, CEO and co-founder of Honic.
“Honic is unique in the European health tech scene as it has been able to develop a data infrastructure aligned with the privacy regulator that can enable large-scale, interdisciplinary medical research. This enables medical research using routinely collected data which is aggregated from different sources . We are delighted to be involved in the next phase of Honic,” said Jan-Frens van Giessel, partner at Holland Capital.
“Holland Capital reinforces Honic’s mission to expand medical science in Germany and Europe. In addition to its financial investment, Holland Capital’s team also supports us with their vast experience and expertise. I am very pleased that we were able to attract international experts such as Harm-Jan Wessels and Achim Plückebaum for the board of Honic,” said Prof. med Jörg F. Debatin, MBA, chairman of the board and co-founder of Honic.
About Honic
Honic was founded by dr. Henrik Matthies and prof. dr. med J. F. Debatin, MBA. The platform, developed in cooperation with the privacy regulator in Germany, uses a unique concept allowing anonymized medical data to be aggregated to generate “Real World” insights for medical research. Since 2022, the platform has been live and successful research projects with universities and international life science companies have been conducted.
About Holland Capital
Over the past 40 years Holland Capital has invested responsibly and successfully in more than 180 Dutch SMEs. With a clear investment strategy it is active in the attractive growth markets Healthcare, Technology and Agrifood. The experienced and committed investment team knows what entrepreneurship is all about. It aims for an open, sustainable and professional relationship with the management teams of the companies it invests in, with the common goal of achieving growth. Holland Capital is supported by a broad network of successful entrepreneurs and has offices in Amsterdam and Düsseldorf.
Quantib presents revolutionary software for dementia and MS diagnosis support and tracking
Rotterdam, The Netherlands – August 1st 2018. Quantib, market leader in artificial intelligence tools for radiology, released a major upgrade of their dementia and MS diagnosis support software Quantib™ ND. A substantial list of new features supporting the diagnosis...
MedAngel takes away doubts about the effectiveness of medication
Digital healthcare startup receives investment from Holland Venture and Oost NLApeldoorn/Amsterdam, 13th of July 2018 – Uncertainties regarding the effectiveness of injectable medications is a major concern for millions of patients. There are many factors that can...
Avensus Group expands its security activitities by acquiring auditconnect
Amsterdam, 6th of July 2018 – Avensus Group acquires AuditConnect at the beginning of July 2018. The company focusses, with audit- and consultancy-activities, on improving the security- and IT-processes at large and medium-sized companies. The acquisition fits...
More strength for Virtual Affairs as part of digital agency We are you.
Holland Venture and management sell their sharesAmsterdam, 25 April 2018 – Earlier this week, the shareholders of fintech company Virtual Affairs signed the contracts to sell their shares to We are you. (a participation of ABN AMRO Participaties). The management team...
Innovation efforts pay off – Gilde Buy Out Partners invests in Esdec
Amsterdam, 26 March 2018 – On 22 March, Gilde Buy Out Partners joined Esdec as a new shareholder. Esdec develops, produces and delivers professional mounting systems for solar panels. The fast growth and the innovative characteristics of Esdec, have fuelled Gilde’s...
Avensus Group acquires ICT Vision and takes the first step with their buy-and-build strategy
Amsterdam, 22 February 2018 – Avensus Nederland, private equity firm Holland Venture, Abram Schermer and Ed Trautig strengthen their ties with the founding of Avensus Group, expanding the partnership they started in the end of 2016. The ambitious buy-and-build...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl